CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner.
about
COP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phaseDynamic regulation of the COP9 signalosome in response to DNA damageThe Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and RepairThe DenA/DEN1 Interacting Phosphatase DipA Controls Septa Positioning and Phosphorylation-Dependent Stability of Cytoplasmatic DenA/DEN1 during Fungal DevelopmentPerspectives of gene combinations in phenotype presentationIntegrating gene expression and protein interaction data for signaling pathway prediction of Alzheimer's disease.Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons.MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neuronsRMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs.Diversity of COP9 signalosome structures and functional consequences.The devil is in the details: comparison between COP9 signalosome (CSN) and the LID of the 26S proteasome.The emerging roles of Jab1/CSN5 in cancer.Delivery strategies and potential targets for siRNA in major cancer typesSystematic characterization of deubiquitylating enzymes for roles in maintaining genome integrityIntegration of the catalytic subunit activates deneddylase activity in vivo as final step in fungal COP9 signalosome assembly.The COP9 Signalosome regulates seed germination by facilitating protein degradation of RGL2 and ABI5.Immunodepletion and Immunopurification as Approaches for CSN Research.Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
P2860
Q24293399-20C37644-90B1-4D30-83D2-2BB4F447F699Q24319983-87878AFA-A117-48DA-99AA-4521166D3A1CQ26782011-6CC1AFA2-9205-45F4-9662-874B0CC22F34Q27309007-A15B3181-E637-46A1-8520-7C2148AA2E9FQ30450809-5CFCEC56-ED00-47DA-B2D3-5CFE3F2B3F09Q30817724-D916FF85-40F0-44D0-8B29-41EFE67FA84BQ36360931-2D12F31C-C370-472D-AF71-97390C8B89CFQ37261417-FBDEBF76-C469-4AD8-8528-7F37016B53CAQ37392814-13582509-0EB4-4661-9B18-A0AAF1117021Q37416686-674722BB-598D-4BC6-9584-3E08E4AD4080Q38533869-1A2567A8-6429-4FBF-9ED7-6DD894D18885Q38615247-358BA8C4-9DF7-458B-AEF4-6099A5860BFEQ38842175-9A40459F-ADDF-4252-ADC8-E3C4F3B18079Q38853191-62511FE4-E109-4DF2-A27E-77C2E3C717F2Q38959150-3F5235E6-0893-42BB-8340-E1FE791BDECFQ41110823-4C95737B-6C9D-4E2E-A73D-0570D8438D0FQ50422504-691B5830-4BE4-4636-98CB-5B534C4F2EEBQ50488789-A24E1DFC-FE7A-4670-9C67-7913F99A0F71Q52657204-E16ABDF1-170B-4207-850D-72791CB8050D
P2860
CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@ast
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@en
type
label
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@ast
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@en
prefLabel
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@ast
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@en
P2093
P2860
P356
P1433
P1476
CSN5 specifically interacts wi ...... smic cyclin E-mediated manner.
@en
P2093
Akihiro Yoshida
Jun-ya Kato
Noriko Yoneda-Kato
P2860
P2888
P356
10.1038/SREP01054
P407
P577
2013-01-11T00:00:00Z